Abstracts (HTML) List of Authors

Bacher, C

Hepatic Disorders Contribute to Platelet Dysfunction

Bacher, M

In vitro characterization of K5A and K5R variants of Factor IX

Bakchoul, T

Platelet activation and apoptosis in COVID-19 infection: data from an observational study

Ballerstädt, N

Treatment of immune thrombocytopenia (ITP) with Eltrombopag – results of the 3 rd interim analysis of the German non-interventional trial RISA. Focussing on steroid-pretreatment and fatigue

Barco, S

Intracranial involvement and neurologic manifestations in Lemierre syndrome: analysis of 712 patients.
The Bacteria-Associated Thrombosis, Thrombophlebitis and LEmierre syndrome (BATTLE) registry: background and rationale.

Baumann, J

Low adhesion and interaction forces of Myh9 mutant platelets lead to impaired clot retraction and unstable thrombus formation
Platelets from patients with MYH9 related disorders are mechanically stiffer

Beer, JH

Red Cell Omega-3 FA Correlate with Reduced DDimer and Beta-Thromboglobulin as Markers of Coagulation Activation in Atrial Fibrillation
Dietary omega-3 fatty acid reverses age-associated platelet hyperreactivity through modulation of gut microbiota

Beier, R

Causes of Acquired von Willebrands Disease Type II in Pediatric Patients. Cases and literature review.

Bendella, H

Assessment of the anticoagulant effect of direct oral anticoagulants (DOACs) in patients needing immediate management during emergency procedures

Bender, M

Low adhesion and interaction forces of Myh9 mutant platelets lead to impaired clot retraction and unstable thrombus formation
Platelets from patients with MYH9 related disorders are mechanically stiffer
Light-induced ion influx triggers megakaryocyte polarization

Bernot, D

GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis
Evolution of platelet phenotype during SARS-CoV-2 infection

Bertaggia Calderara, D

Evaluation of different processing methods to label platelets for in vivo studies
Usefulness of global assays to monitor treatment of a patient with Hemophilia A switching from factor to non-factor replacement therapy
Epinephrine enhances platelet aggregation at the expense of procoagulant activity
Efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis at high thrombotic risk

Bertschi, DA

Red Cell Omega-3 FA Correlate with Reduced DDimer and Beta-Thromboglobulin as Markers of Coagulation Activation in Atrial Fibrillation

Bianco, AM

The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms

Bidlingmaier, C

Newly diagnosed children and adolescents with haemophilia A and B in Germany – the GEPHARD study of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research

Biffi, A

The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms

Binder, M

A Phase II study to investigate the efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed primary ITP (XPAG-ITP)

Binder, NB

Heparinase treatment to remove the inhibitory heparin effect on the thrombin generation assay
Use of a Universal Calibrator for Direct FXa inhibitor DOACs
Comparing automated FXIII assays

Birschmann, I

Von Willebrand factor ratio as a risk factor for bleeding in aortic valve stenosis replacement surgery
Retrospective analysis of persons after mild COVID-19 in the context of a convalescent plasma donation

Bitzer, M

Platelet activation and apoptosis in COVID-19 infection: data from an observational study

Block, AC

Thrombophilic Phaenotype in a Family with High Frequency of Homozygous Antithrombin Deficiency Typ IIb Budapest 3 and Mild Factor VII Deficiency due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment

Block, H

Examination of the Rac-modulator ArhGAP15 in platelet activation.

Bobek, I

Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients

Bock, H

Reelin supports Glycoprotein VI and integrin outside-in signaling of platelets

Bockel, S

Performance evaluation of the BIOPHEN chromogenic test for Factor XIII activity on the Cobas c502 System

Böddeker, C

Impact of osteopontin on platelet adhesion and activation in intraluminal thrombus formation and abdominal aortic aneurysm progression

Bode, C

Differences in venous thromboembolism prophylaxis between gastroenterology and cardiology inpatients.

Boeckelmann, D

Next-generation sequencing identified different types of Hermansky-Pudlak syndrome associated with phenotype variability

Boggio, L

Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Early Bleed Resolution for Persons with Hemophilia A or B with Inhibitors: Results of the randomized cross-over PERSEPT 1 phase 3 study

Boireau, W

Assessment of primary hemostasis with an acoustic biosensor using shear dependent kinetics behavior: principle and limitations

Bomke, B

Acquired von Willebrand syndrome associated with monoclonal gammopathy of undetermined significance – successful treatment with lenalidomide and dexamethasone

Bonanad, S

A matching‐adjusted indirect comparison in patients with severe haemophilia A: Comparing the efficacy and consumption of rVIII-SingleChain vs two recombinant FVIII

Bonetti, NR

Dietary omega-3 fatty acid reverses age-associated platelet hyperreactivity through modulation of gut microbiota

Bönig, H

AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B Confirms Stable FIX Expression and Sustained Reductions in Bleeding for up to 5 Years

Bönigk, H

Application of the STG-Bleedscreen assay in clinical routine

Bontekoe, E

A Comparison of Functional Methods with Absolute Quantification of Heparin Levels in Clinical Samples by Heparin Red Assay
Changes in Vascular Physiology in Patients with ESRD Compared to Patients with ESRD and Concomitant Cardiovascular Disorder
Sulodexide as a Parenteral Anticoagulant. A Substitute for Unfractionated Heparin.
Whole blood anticoagulant effects of Sulodexide as measured by activated clotting time and their neutralization by Protamine sulfate
Sheep Mucosal Heparin as a Substitute for Porcine Mucosal Heparin. A Viable Option to Address the Potential Shortage Crisis.

Bonzo, D

Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Early Bleed Resolution for Persons with Hemophilia A or B with Inhibitors: Results of the randomized cross-over PERSEPT 1 phase 3 study

Bordet, JC

GATA1 pathogenic variants disrupt MYH10 silencing during megakaryopoiesis

Borel-Derlon, A

Safety and efficacy of a high-purity plasma derived von Willebrand Factor in patients with von Willebrand disease (VWD) undergoing prophylaxis for joint bleeding: results from a post-marketing study
Safety and efficacy of a high-purity plasma-derived von Willebrand Factor in patients with von Willebrand disease (VWD) undergoing prophylaxis for gastrointestinal bleeding: results from a post-marketing study

Bortoluzzi, S

Microvascular immune cell recruitment regulating development of immunothrombosis in systemic bacterial infection

Bösmüller, H

Platelet activation and apoptosis in COVID-19 infection: data from an observational study

Bottega, R

Functional assays to unravell the pathogenetic role of variants found in GFI1B in piastrinopenic patients
The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms

Bourgeois, O

Assessment of primary hemostasis with an acoustic biosensor using shear dependent kinetics behavior: principle and limitations

Bovet, C

A universal anti-Xa assay for the determination of rivaroxaban, apixaban, and edoxaban drug levels: development, diagnostic accuracy, and external validation
Accuracy of the STA®-Liquid anti-Xa assay in clinical practice: results from a large cross-sectional study in Switzerland

Bradacova, P

Detection thrombogenicity antiphospolipid antibodies with APC modified TGT
Non-criteria antiphospholipid antibodies anti-PT/PS, anti-Anexin V: benefit in diagnostics of antiphospholipid syndrome?

Brandenburger, C

Von Willebrand factor ratio as a risk factor for bleeding in aortic valve stenosis replacement surgery

Brehm, MA

Characterization of activity and cleavage of von Willebrand disease type 2B variants

Brinkkoetter, PT

Treatment of acquired thrombotic thrombocytopenic without plasma exchange in selected patients under caplacizumab

Brouns, S

Platelet-derived chemokines regulating neutrophil activation stages in arterial thrombus formation

Buchtele, N

Prevalence and clinical impact of reduced FXII activity in patients receiving extracorporeal membrane oxygenation
Clinical usefulness of the novel DOAC Dipstick near patient test strip in emergency settings using semi-automatic DOASENSE Reader
Abnormal urine is detected by a specific pad of DOAC Dipstick near patient test strip
A bedside urine based test strip on identifying anticoagulation with direct oral anticoagulants at a high-volume emergency department – a diagnostic test accuracy study

Budde, U

Characterization of activity and cleavage of von Willebrand disease type 2B variants
Von Willebrand factor ratio as a risk factor for bleeding in aortic valve stenosis replacement surgery
Case report: Use of recombinant von Willebrand factor in a patient with acquired von Willebrand syndrome due to specific IgM-antibodies directed against vWF

Buresch, L

Factors influencing bleeding severity in adult patients with primary immune thrombocytopenia

Burlina, A

The Glycosylation Nexus Enigma: new clues to the role of the GNE gene in the pathogenesis of inherited thrombocytopenia in both isolated and myopathy-associated forms

Buxhofer-Ausch, V

Treatment of acquired thrombotic thrombocytopenic without plasma exchange in selected patients under caplacizumab